I'm creating another account just for you! Learn How I Plan to Turn

$5,000 into $25,000

Phase 1: $5,000 - $25,000 (estimated time needed: 3 months)

Most new traders think you need a huge account to make money in the market, but that is completely false. I'm going to show you exactly how it's done, starting with just $5,000. Trade over my shoulder!

Phase 2: $25,000 - $200,000 (estimated time needed: 3 months)

I started this 2 months ago and have taken $25000 into over $100,000. I will keep growing this account and helping every step of the way. The $5,000 account will be another individual account. No matter the stage you're in, I've got you covered!

Phase 3: $200,000 - $1,000,000 (estimated time needed: 1 year)

This is where I'll show you how to use $200,000 to make $1,000,000+ yearly. And since I normally trade with about $200,000 in my account, you'll learn EVERY account hacking strategy I have, something I call 'trading buckets' to make $1,000,000+ each year

Trading stocks is inherently risky. There is no guarantee you will make money or replicate Kyle's performance nor that Kyle will be able to replicate past results.

How to Join Me

  1. Only for BiotechBreakouts.com Nucleus subscribers
  2. Phase I starts January 2nd, 2018.
  3. Phase II has begun. I've turned $25,000 into over $100,000 so far. Everything is being recorded.
  4. If you have a small account, you need to be in here before the new year starts. I'm taking $5,000 to $25,000 and want you to do it with me!

| save 70% with promocode: xmas70

SAVE 70% NOW! Deal ends in:

FEATURED CONTENT

No More Need to Fear a Down Market

Kyle Dennis’ newly released system tracks $1 contracts so traders of all account sizes can be on the “inside” and find huge returns.
Wall Street simply knows something that we don’t, UNTIL NOW, and it’s time for you to take your share of the profits!

Stocks are up this afternoon, as they look to close out strong, and post some of the best weekly gains we’ve seen all year.

The catalyst:  bad news.

The jobs numbers were awful this morning… which helps the case for the Federal Reserve Bank cutting interest rates this year. As of now, the market is predicting a 36% chance of a rate cut in June, and a greater than 75% chance of a cut in July.

Make no mistake about it… this is still a news-driven market.

And to be perfectly transparent, I don’t try to trade macro events because I don’t think that’s where my edge is…

Believe it or not… some stocks aren’t moving off trade headlines or dovish fed comments…

… and those are the types of trades I’m going after right now…

… and having a great deal of success.

For example, it was a relatively slow week for me… that is… until one of my FDA Insider Alerts trades hit the jackpot!

It was a classic catalyst runup … a strategy that I teach in my advanced biotech trader course, which you get for free when you’re a member of FDA Insider Alerts.

 

 (If you need a place to start then my FDA Insider Alerts is what I recommend, click here to find out more)

 

That said, I am going to walk you through the trade in vTv Therapeutics (VTVT) by explaining the play, how I found it, and how I decided on entry and exit points.

 

Catalyst Runup Strategy Has Been Working Well

 

In my last post, I talked about reviewing your trades so you can maximize your profits.

Now, if you don’t know, one of my best trading strategies is my FDA catalyst runup strategy… if that sounds unfamiliar to you, or a bit complex… don’t worry, it’s really not.

Basically, what I’m looking for here is an upcoming catalyst in a biotech stock, and pair that with a chart pattern I like.

Why’s that?

Well, generally, the stock runs up into the catalyst event… and if you’re able to spot these, you can realize large gains.

Now, we’re going to get right into things here and go over not one… but two recent trades I had using this strategy… in the same stock.

 

FDA Catalyst Runup Strategy

 

For the most part, I like to use BioPharmCatalyst to spot upcoming catalyst events for biotech stocks.

You see, I look to see what the upcoming catalysts are… if I think the stock could run up into the catalyst… then I’ll look to the chart, and typically, I scan for stocks to trade using Finviz.

Now, you can scan for stocks first and then look to see if they have catalysts… or look for catalysts, then look at the chart setup.

For example, one quick screener I like to do is this (just hit screener when you go to Finviz.com):

Source: Finviz

 

Now, under the screener, you’ll see a tab for “Charts”.

 

Source: Finviz

 

This allows me to quickly scan through dozens of stocks and find patterns that I like.

Thereafter, I develop a trading plan and put it on my watchlist, which I send out to clients regularly… it’s exactly how I found winning trades in VTVT.

For example, I sent this out to FDA Insider Alerts clients a few weeks ago…

 

 

Notice how the stock caught a pop and got right into my buy zone – between $1.25 to $1.50.

Why did I like it at that level?

Well, check out this daily chart in VtV Therapeutics (VTVT).

 

 

Notice that blue line there? Well, that’s support.

I want to be long the stock as close to support as possible, and stop out somewhere below that.

Now, I don’t just send these plans out… I actually trade them and let clients know exactly where I’m buying the stock.

 

 

Now, I actually bought more shares… because I felt really strongly about this stock running up into the catalyst.

Just a few weeks later, I took some profits off the table – locking in $4K!

 

 

Thereafter, I took the rest off the table…

 

 

Remember, whenever you find a strategy that’s been proven to work… you press it.

I went back to the well and decided to buy more shares, and of course, I let my clients know about the trade.

 

 

Just a few days later, the stock was up 30% in the pre-market, and I sold most of my position for $7,200 in realized profits! Of course, I let clients know I was getting out of the position.

 

 

Well, what happened here?

I was anticipating the stock to have a press release or some type of data about its diabetes treatment trial…

… and they reported positive results in the morning.

More specifically, the headline was:

“vTv Therapeutics Announces Positive Topline Results from Part 1 of the Phase 2 Simplici-T1 Trial in Patients with Type 1 Diabetes”

Now, if the catalyst runup strategy is still unfamiliar to you… or if you just simply need a refresher on how key data releases affect biotech stocks, click here to find out more.

Stay tuned for my next post (you can find that and other trading lessons here), where I go over one of my longer-term trades that was up 71% from my entry after destroying earnings yesterday!

You May Also Like:

Exclusive System Tracks Wall St. Insiders

“Dollar Ace Simply Exposes Information That Wall Street Wants To Keep Quiet” Said Kyle Dennis
“One member, Wesley M., has already reported 360%+ gains in just a few short days. Don’t miss this!”
(Reserve Access Now)

“What Recession?!” Jason Bond nets $55,060 in realized profit in One Day

After going 6 for 6 on profitable trades recently, we caught up with Jason to ask how he did it.
Check out Jason’s exclusive interview revealing this tightly guarded strategy. (Watch Now)

RagingBull.com Co-Founder, Jeff Bishop, Launches High Conviction Trade Service

“We listen to our clients and we give them EXACTLY what they want, so we designed a service to deliver 1 trade, 1 time a week, with a 100%+ PROFIT TARGET, directly to your inbox every Monday before the market opens.” (Read More)